Kenvue Inc. Kenvue Inc.

Kenvue Inc.

KVUE

Rank in Stocks #662
Kenvue Inc. functions as a global leader in the consumer health sector. The... Kenvue Inc. functions as a global leader in the consumer health sector. The company structures its operations across three primary divisions: Self Care, Skin Health and Beauty, and Essential Health. Within the Self Care unit, it offers a diverse range of products for common conditions like coughs, colds, and allergies, in addition to pain relief, digestive health, and smoking cessation aids, featuring prominent brands such as Tylenol, Nicorette, and Zyrtec. The Skin Health and Beauty segment delivers various solutions for facial, body, hair, and sun protection, recognized under popular labels including Neutrogena, Aveeno, and OGX. Moreover, the Essential Health category provides oral hygiene, infant care, feminine wellness, and wound treatment products, marketed through esteemed brands like Listerine, Johnson's, Band-Aid, and Stayfree. Established in 2022, Kenvue Inc. maintains its corporate headquarters in Skillman, New Jersey, and operates as a subsidiary of Johnson & Johnson.
Share Price
$19.29
Market Cap
$37.05B
Change (1 day)
2.23%
Change (1 year)
28.94%
Country
US
Trade Kenvue Inc. (KVUE)

Category

Consumer Defensive
Number of shares outstanding for Kenvue Inc. (KVUE)
Number of shares outstanding as of June 2026: 1.92B
According to Kenvue Inc. latest financial reports and stock price the company's current number of shares outstanding is 1.92B. At the end of December 2023 the company had 1.85B shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Kenvue Inc. (KVUE) from 2019 to 2026
Shares Outstanding at the end of each year
Year Shares Outstanding Change
2026 (TTM) 1.92B 0.26%
2024 1.92B 3.58%
2023 1.85B -3.45%
2022 1.91B 1.37%
2021 1.89B 0.00%
2020 1.89B 0.00%
2019 1.89B 0.00%
Shares Outstanding for similar companies or competitors
Company Shares Outstanding Difference Country
2.42B 26.17%
US
533.97M -72.19%
FR
0.00 -100.00%
US
2.35B 22.34%
IN
362.30M -81.13%
US